Lifileucel

Drug identity checked against registry records

Also recorded as LN - 144; LN-144; LN-144, TIL, autologous tumor-infiltrating lymphocytes; LN-145; TIL; Tumor-Infiltrating Lymphocytes

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.